Overview

Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury

Status:
Completed
Trial end date:
2019-03-27
Target enrollment:
Participant gender:
Summary
Study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of Rec 0/0438 in subjects with neurogenic detrusor overactivity due to spinal cord injury
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
RECORDATI GROUP